Severe Pseudomonas aeruginosa infections -: Tackling the conundrum of drug resistance

被引：33

作者：

Hauser, AR

Sriram, P

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Div Infect Dis, Chicago, IL 60611 USA

[2] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Infect Dis, Chicago, IL 60611 USA

来源：

POSTGRADUATE MEDICINE | 2005年 / 117卷 / 01期

关键词：

D O I：

10.3810/pgm.2005.01.1571

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pseudomonas aeruginosa infections are a frequent cause of morbidity and mortality in hospitalized patients. Treatment of these infections is complicated by the intrinsic and acquired resistance of this bacterium to many commonly used antimicrobial agents. In this article, Drs Hauser and Sriram argue that careful consideration of the mechanisms by which P aeruginosa resists the activity of antimicrobial agents is essential for optimal treatment decisions. Although many aspects of treatment of severe P aeruginosa infections remain controversial, the authors suggest specific treatment options for patients both before and after susceptibilities are known.

引用

页码：41 / 48

页数：8

共 27 条

[1] Emergence of antibiotic-resistant Pseudomonas aeruginosa:: Comparison of risks associated with different antipseudomonal agents [J].

Carmeli, Y ;

Troillet, N ;

Eliopoulos, GM ;

Samore, MH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1379-1382

[2] Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia [J].

Chamot, E ;

El Amari, EB ;

Rohner, P ;

Van Delden, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) :2756-2764

[3] COMPARISON OF THE ACTIVITY OF ANTIBIOTIC COMBINATIONS INVITRO WITH CLINICAL OUTCOME AND RESISTANCE EMERGENCE IN SERIOUS INFECTION BY PSEUDOMONAS-AERUGINOSA IN NON-NEUTROPENIC PATIENTS [J].

CHANDRASEKAR, PH ;

CRANE, LR ;

BAILEY, EJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 19 (03) :321-329

[4]

CROUCH BS, 1996, CHEST, V109, P1019, DOI DOI 10.1378/CHEST.109.4.1019

[5]

El Amari EB, 2001, CLIN INFECT DIS, V33, P1859, DOI 10.1086/324346

[6]

FEKETE T, 1996, AM J MED S6A, V100, P20

[7] TREATMENT OF SEVERE PNEUMONIA IN HOSPITALIZED-PATIENTS - RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING INTRAVENOUS CIPROFLOXACIN WITH IMIPENEM-CILASTATIN [J].

FINK, MP ;

SNYDMAN, DR ;

NIEDERMAN, MS ;

LEEPER, KV ;

JOHNSON, RH ;

HEARD, SO ;

WUNDERINK, RG ;

CALDWELL, JW ;

SCHENTAG, JJ ;

SIAMI, GA ;

ZAMECK, RL ;

HAVERSTOCK, DC ;

REINHART, HH ;

ECHOLS, RM ;

HELSMOORTEL, C ;

SOJASTRZEPA, D ;

SCHWAITZBERG, S ;

BAREFOOT, L ;

FEIN, AM ;

FEINSILVER, SH ;

ILOWITE, JS ;

CLARE, N ;

SCHULMAN, D ;

JONES, CB ;

GRIFFIN, RI ;

WROBEL, CW ;

BALLOW, CH ;

AMSDEN, G ;

MITCHELL, P ;

BESS, T ;

WILKINS, W ;

BROWN, RB ;

MCGEE, W ;

SAFFORD, MJ ;

LEVINE, DP ;

LERNER, SA ;

KRUSE, JA ;

BANDER, JJ ;

MCNEIL, P ;

MUNKARAH, M ;

SUMMER, WR ;

DEBOISBLANC, B ;

LEVISON, ME ;

KORZENIOWSKI, O ;

SIGLER, A ;

BALDASSARRE, J ;

WALSH, P ;

SAMEL, C ;

SESSLER, CN ;

POLK, RE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :547-557

[8] Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2 [J].

Fridkin, SK ;

Steward, CD ;

Edwards, JR ;

Pryor, ER ;

McGowan, JE ;

Archibald, LK ;

Gaynes, RP ;

Tenover, FC .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :245-252

[9] Characterization of Pseudomonas aeruginosa isolates:: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999 [J].

Gales, AC ;

Jones, RN ;

Turnidge, J ;

Rennie, R ;

Ramphal, R .

CLINICAL INFECTIOUS DISEASES, 2001, 32 :S146-S155

[10] Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa [J].

Harris, A ;

Torres-Viera, C ;

Venkataraman, L ;

DeGirolami, P ;

Samore, M ;

Carmeli, Y .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :1128-1133

← 1 2 3 →